Chief Executive Officer to continue as a Non-executive Director

Mediclinic, a leading international private healthcare services group, announces that on 23 May 2018, the Board agreed that, subject to Mr Danie Meintjes’ re-election as a director of the Company at the Annual General Meeting to be held on 25 July 2018, he will continue to serve as an executive director until 31 July 2018 and as a non-executive director with effect from 1 August 2018. As previously announced on 29 March 2018, Dr Ronnie van der Merwe will succeed Mr Meintjes as Chief Executive Director on 1 June 2018.

Mediclinic’s chairman, Dr Edwin Hertzog commented:

“Danie’s continued role as a non-executive director of the Company after his retirement as CEO was made after careful consideration by the Nomination Committee and the Board. This appointment is considered to be in the long-term interest of Mediclinic, its shareholders and other stakeholders in view of the wealth of knowledge and experience Danie has gained in different capacities over 30 years at Mediclinic.”

Investor Contacts
James Arnold
Head of Investor Relations
Media Contacts
FTI Consulting